Bausch + Lomb Micronizes Lutein, Zeaxanthin In PreserVision OCUSorb

Analysts: No Small Impact On B+L Credit Rating From Bausch Health Continued Ownership

PreserVision AREDS 2 mini-softgel has proprietary OCUSorb formulation with micronized ingredients in a medium-chain triglyceride oil. More than line extensions, though, are needed for B+L to shed influence from Bausch Health’s credit rating.

• Source: Shutterstock

Bausch + Lomb Corp. isn’t resting on the laurels of its consumer health eye care products to drive sales after its spinout from its parent firm in 2022. It’s extending the PreserVision AREDS 2 lutein and zeaxanthin supplement line with a mini-softgel using its proprietary OCUSorb formulation made with micronized forms of the ingredients.

More than line extensions, though, are needed for B+L to separate from Bausch Health Companies Inc. enough to shed...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

More from Geography